#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16036	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2121	750.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1780	1780	T	953	T,C	862,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16036	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2121	750.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1514	1514	C	914	C	846	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28524	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3630	784.1	0	.	n	.	0	T695C	SNP	695	695	T	1119	1119	C	844	C,T,A,G	780,1,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28524	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3630	784.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1761	1761	A	939	A	865	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28524	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3630	784.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2395	2395	C	860	C	787	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28524	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3630	784.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2469	2469	A	888	A	837	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28524	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3630	784.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3021	3021	C	904	C	849	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2176	folP	855	855	100.0	folP.l15.c4.ctg.1	1575	137.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1109	1111	AGC	238;234;234	A;G;C	228;223;221	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6402	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3400	187.9	1	SNP	p	S91F	1	.	.	271	273	TTC	542	544	TTC	193;194;195	T;T;C	183;183;182	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6402	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3400	187.9	1	SNP	p	G95N	0	.	.	283	285	GGC	554	556	GGC	199;199;198	G;G;C	184;179;178	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6402	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3400	187.9	1	SNP	p	D95G	1	.	.	283	285	GGC	554	556	GGC	199;199;198	G;G;C	184;179;178	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1706	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1291	131.6	1	SNP	p	G45D	0	.	.	133	135	GGC	467	469	GGC	226;230;232	G;G;C,T,G	208;212;210,1,1	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	836	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1042	80.0	0	.	n	.	0	A197.	DEL	197	197	A	579	579	A	182	A	176	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5642	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2886	194.6	1	SNP	p	D86N	0	.	.	256	258	GAC	553	555	GAC	218;217;217	G;A;C	203;203;204	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5642	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2886	194.6	1	SNP	p	S87R	1	.	.	259	261	CGT	556	558	CGT	221;222;224	C,A;G;T	206,1;207;209	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5642	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2886	194.6	1	SNP	p	R87W	0	.	.	259	261	CGT	556	558	CGT	221;222;224	C,A;G;T	206,1;207;209	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5642	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2886	194.6	1	SNP	p	R87I	0	.	.	259	261	CGT	556	558	CGT	221;222;224	C,A;G;T	206,1;207;209	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5642	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2886	194.6	1	SNP	p	S88P	0	.	.	262	264	TCC	559	561	TCC	225;226;225	T;C;C	212;214;212	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4600	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2634	173.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1492	1494	GGC	193;191;190	G;G;C	181;180;177	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4084	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2444	166.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1228	1230	GCA	208;208;210	G;C;A	196;195;200	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4084	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2444	166.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1231	1233	ATC	212;211;210	A;T;C,G	198;196;196,1	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4084	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2444	166.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1243	1245	GTG	205;205;206	G;T;G	188;188;189	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4084	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2444	166.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1243	1245	GTG	205;205;206	G;T;G	188;188;189	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4084	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2444	166.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1747	1749	ACC	181;181;181	A;C;C	169;170;173	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4084	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2444	166.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1801	1803	GCG	172;173;178	G;C;G	157;141;155	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4084	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2444	166.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1801	1803	GCG	172;173;178	G;C;G	157;141;155	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4084	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2444	166.4	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1924	1926	AGC	154;155;156	A;G;C	144;147;148	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4084	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2444	166.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1933	1935	GGC	157;156;156	G;G;C	147;144;146	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4084	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2444	166.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1951	1953	CCG	145;149;151	C,CGG;C;G	102,1;112;108	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	5956	ponA	2397	2397	99.96	ponA.l6.c30.ctg.1	3250	182.6	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1525	1527	ACG	229;228;228	A;C;G	212;208;208	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	5956	ponA	2397	2397	99.96	ponA.l6.c30.ctg.1	3250	182.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1663	1665	CCG	215;213;213	C;C;G	192;199;191	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2654	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1845	143.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	546	546	C	204	C	189	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2910	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1648	175.7	0	.	p	.	0	N38E	NONSYN	112	114	AAT	415	417	GAA	250;251;248	G;A;A	231;230;230	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2910	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1648	175.7	0	.	p	.	0	N134D	NONSYN	400	402	AAT	703	705	GAT	227;227;228	G;A;T	213;212;214	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2910	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1648	175.7	0	.	p	.	0	P175S	NONSYN	523	525	CCA	826	828	TCA	251;252;255	T;C;A	235;235;239	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2910	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1648	175.7	0	.	p	.	0	A218V	NONSYN	652	654	GCC	955	957	GTC	257;254;253	G;T;C	236;230;229	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2910	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1648	175.7	0	.	p	.	0	F222S	NONSYN	664	666	TTT	967	969	TCT	251;249;251	T;C;T	231;233;234	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2910	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1648	175.7	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1285	1287	GCA	219;219;220	G;C;A	202;198;202	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2910	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1648	175.7	1	SNP	p	G120K	1	.	.	358	360	AAG	661	663	AAG	207;211;214	A;A;G	193;198;201	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2910	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1648	175.7	1	SNP	p	A121D	1	.	.	361	363	GAC	664	666	GAC	216;216;215	G;A;C	202;202;200	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2910	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1648	175.7	1	SNP	p	D121N	0	.	.	361	363	GAC	664	666	GAC	216;216;215	G;A;C	202;202;200	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10494	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4812	217.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1074	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1113	96.0	1	SNP	p	V57M	1	.	.	169	171	ATG	598	600	ATG	211;211;212	A;T;G	202;203;203	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
